{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Lenexa",
      "address_1": "12076 Santa Fe Trail Dr",
      "reason_for_recall": "The product may contain high levels of microbial contamination",
      "address_2": "",
      "product_quantity": "44/10/500-ml. vial boxes",
      "code_info": "Lot 1380784, Exp. 31Aug2015, and Lot 1367905, Exp. 31Jul2015",
      "center_classification_date": "20140226",
      "distribution_pattern": "US Distribution including Puerto Rico and the states of FL, IL, MA, ME, MI, and PA.",
      "state": "KS",
      "product_description": "Oxoid Legionella BCYE Growth Supplement, For 500 ml of medium, SR0110C, packaged 10 vials/box, lyophilized.  The firm name on the label is Oxoid Ltd., Basingstoke, Hants, England.     The product is used for the isolation of Legionella species from clinical and environmental samples. When the product is added to CYE Agar base, it stabilizes pH and provides essential growth factors for the isolation of the Legionella spp.",
      "report_date": "20140305",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Remel Inc",
      "recall_number": "Z-1112-2014",
      "initial_firm_notification": "Letter",
      "product_type": "Devices",
      "event_id": "67415",
      "termination_date": "20140723",
      "more_code_info": "",
      "recall_initiation_date": "20140124",
      "postal_code": "66215-3519",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}